Article Details
Retrieved on: 2024-06-28 17:43:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Bloomberg) -- Shares of Alumis Inc. sank 20% in the clinical stage biopharmaceutical company's public debut, after it raised $250 million in a ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here